Turning Point Benefit Group’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
Turning Point Benefit Group's IBD Position: Q2 2026 in Review
Turning Point Benefit Group reduced its Inspire Corporate Bond ETF (IBD) stake by 57% in Q2 2026, selling an estimated $620K and leaving 19,600 shares worth $466K. The position accounts for 0.2% of the portfolio, ranked #72.
Turning Point Benefit Group first reported a position in IBD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.09M in Q1 2026. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- Turning Point Benefit Group held 19,600 shares of Inspire Corporate Bond ETF worth $466K as of Q2 2026.
- Turning Point Benefit Group sold 25,983 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $620K.
- Inspire Corporate Bond ETF made up 0.2% of Turning Point Benefit Group's portfolio in Q2 2026, its #72 holding.
- Turning Point Benefit Group first reported a position in Inspire Corporate Bond ETF in Q4 2024 and has held it in 6 quarters since.
- Turning Point Benefit Group's Inspire Corporate Bond ETF position peaked at $1.09M in Q1 2026.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on Turning Point Benefit Group's 13F filing for Q2 2026, filed 23 Jul 2026.